Condition
Arsenical Keratosis
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 5 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (1)
P 3 (1)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03127670Phase 2CompletedPrimary
Effect of Solanum Melongena Extract in the Treatment of Arsenical Skin Lesion
NCT01735097Not ApplicableCompletedPrimary
Effect of Nigella Sativa in the Treatment of Palmer Arsenical Keratosis
NCT01731756Not ApplicableCompletedPrimary
Effects of Leaf Extract of Azadirachta Indica in Palmer Arsenical Keratosis
NCT01752972Not ApplicableCompletedPrimary
Effect of Spirulina on Zinc, Vitamin E and Linoleic Acid Levels in Palm Skin Following Chronic Exposure to Arsenic
NCT01442727Phase 3Completed
Selenium in the Treatment of Arsenic Toxicity and Cancers
Showing all 5 trials